Ignite Creation Date:
2024-05-06 @ 1:26 PM
Last Modification Date:
2024-10-26 @ 1:14 PM
Study NCT ID:
NCT04029441
Status:
UNKNOWN
Last Update Posted:
2019-07-23
First Post:
2019-07-21
Brief Title:
The Effact of Helicobacter Hylori Eradication on the Development of Gastric Mucosa Pathology
Sponsor:
Shandong University
Organization:
Shandong University
Study Overview
Official Title:
he Effact of Helicobacter Hylori Eradication on the Development of Gastric Mucosa Pathology
Status:
UNKNOWN
Status Verified Date:
2019-07
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Subjects who are included will recieve Hp eradication therapy based on antimicrobial susceptibility test After the therapy the subjects will be divided into two groups the successful group and the failure group And then they wiil be followed up to observe the development of the gastric mucosa pathology
Detailed Description:
Subjects who are included will recieve Hp eradication therapy based on antimicrobial susceptibility test After the therapy the subjects will be divided into two groups the successful group and the failure group The subjects who fail to eradicate the Hp after initial treatment and rescue treatment will go into the failure group Otherwhile they will go to the successful groupAnd then they wiil be followed up to observe the development of the gastric mucosa pathology For mild atrophy gastritis non- intestinal metaplasial gastritis follow-up is performed every 2-3 yearsFor severe atrophy gastritis intestinal metaplasial gastritis follow-up is performed every 1-2 years For patients wth high-grade intraepithelial neoplasia they can be included 3 months after the endoscopic treatment and the follow up will be performed at 6 12 months after the treatment and then the follow up will be carried out every 1 year For non-atrophic gastritis no follow-up will be performed All included patients will recieve a follow-up at the endpoint of 5 years The follow-up includes endoscopy examination and serum test of PG IPG II and gastrin 17
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None